Equisil BDS C8 is a reversed-phase HPLC column based on fully porous, high-purity silica, bonded with octyl chains and treated with base deactivation (BDS) to reduce silanol activity. This results in better peak symmetry, especially for basic analytes, while offering moderate hydrophobic retention — making it ideal for faster analyses and compounds that are too strongly retained on C18 phases. Equisil BDS C8 delivers stable, reproducible performance and is suitable for routine reversed-phase applications in pharmaceutical, food, and general analytical laboratories.
Equisil BDS C8 offers improved peak shape and balanced retention – an ideal reversed-phase column for fast, reliable, and reproducible HPLC separations.
Octyl (C8) bonded phase with base deactivation – USP L7
Reduced peak tailing for basic and polar compounds
Moderate hydrophobic retention for faster separations
Fully porous silica with excellent reproducibility
Available in 3 µm, 5 µm and 10 µm particle sizes
Basic drugs, impurities, and formulation screening
Routine QC and method development
Food and beverage additive analysis
Environmental and chemical sample profiling
| Particle Sizes |
|
|---|---|
| Pore Size | 130 Å |
| Surface Area | 170 m²/g |
| Phase/Modification | C8 |
| Particle Type | |
| Separation Mode | |
| USP Code | |
| Endcapping | Yes |
| Carbonload | 7 % |
| pH Range | 2 to 8 |
| Phase | Material Number |
|---|---|
| Equisil BDS C8, 3 µm | e23.8b. |
| Equisil BDS C8, 5 µm | e25.8b. |
| Equisil BDS C8, 10 µm | e20.8b |